Alector Inc
F:0Z2
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
A
|
Alector Inc
F:0Z2
|
US |
|
A
|
American Tower Corp
F:A0T
|
US |
|
L
|
Lindbergh SpA
MIL:LDB
|
IT |
|
B
|
Big Cheese Studio SA
WSE:BCS
|
PL |
|
D
|
Descartes Systems Group Inc
F:DC2
|
CA |
|
W
|
Wipro Ltd
F:WIOA
|
IN |
|
L
|
Lloyds Banking Group PLC
F:LLD
|
UK |
|
N
|
Novartis AG
XHAM:NOT
|
CH |
|
H
|
HaTay Pharmaceutical JSC
VN:DHT
|
VN |
|
Erie Indemnity Co
F:EI2
|
US |
Intrinsic Value
Is 0Z2 undervalued or overvalued?
See the intrinsic value estimate for 
Alector Inc and find out whether today’s valuation is cheap or expensive by its own historical standards.
Do our valuations actually work? See backtest results .
0Z2 looks overvalued.
But is it expensive by its own standards?
See how today’s valuation compares with 0Z2’s past valuations and how the stock performed after similar periods.
Fundamental Analysis
What Alector Does
Alector Inc. is a clinical-stage biotechnology company working on medicines for brain diseases such as Alzheimer’s and frontotemporal dementia. Its idea is to use the body’s immune system, especially cells in the brain called microglia, to help clear harmful proteins and slow disease progression. The company does not sell approved drugs itself; it develops drug candidates and tests them in clinical trials.
- Headquarters
- United States of America US
- Employees
- 103
- IPO date
- Feb 7, 2019
Revenue & Expenses Breakdown
Alector Inc
Earnings Waterfall
Alector Inc
The intrinsic value for Alector Inc (0Z2) under the Base Case is hidden EUR.
Compared with the current market price of 1.861 EUR, the stock appears hidden.